Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07070024Phase 2Not yet recruiting
Phase 2, randomised, open-label trial of ascorbic acid in gingival hyperpigmentation (3 arms), sponsored by Fayoum University. Primary endpoint: Efficacy of gingival depigmentation at 6 months. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07070024.